Healthcare provider profile · identity verified

Glen Scott Smith, M.D.

Family Practice · ORANGE, CA · NPI 1912096579

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	324	93
Atorvastatin Calcium	Atorvastatin Calcium	280	80
Famotidine	Famotidine	253	87
Levothyroxine Sodium	Levothyroxine Sodium	233	61
Amlodipine Besylate	Amlodipine Besylate	231	75
Tamsulosin Hcl	Tamsulosin Hcl	173	47
Metformin Hcl Er	Metformin Hcl	172	60
Gabapentin	Gabapentin	162	57
Hydrochlorothiazide	Hydrochlorothiazide	138	43
Trazodone Hcl	Trazodone Hcl	135	38
Metoprolol Succinate	Metoprolol Succinate	130	42
Furosemide	Furosemide	129	42
Pantoprazole Sodium	Pantoprazole Sodium	117	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	100	17
Hydralazine Hcl	Hydralazine Hcl	94	23
Lisinopril	Lisinopril	92	29
Metformin Hcl	Metformin Hcl	90	25
Rosuvastatin Calcium	Rosuvastatin Calcium	90	31
Carvedilol	Carvedilol	89	27
Terazosin Hcl	Terazosin Hcl	85	26
Zolpidem Tartrate	Zolpidem Tartrate	85	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	83	24
Finasteride	Finasteride	78	21
Escitalopram Oxalate	Escitalopram Oxalate	70	18
Atenolol	Atenolol	69	23
Clonazepam	Clonazepam	67	11
Simvastatin	Simvastatin	66	20
Omeprazole	Omeprazole	64	21
Meloxicam	Meloxicam	61	19
Eliquis	Apixaban	60	21
Memantine Hcl	Memantine Hcl	60	16
Tramadol Hcl	Tramadol Hcl	60	28
Valsartan	Valsartan	59	18
Allopurinol	Allopurinol	58	18
Fentanyl	Fentanyl	54	suppressed
Potassium Chloride	Potassium Chloride	54	15
Spironolactone	Spironolactone	52	19
Prednisone	Prednisone	51	30
Alprazolam	Alprazolam	50	17
Pravastatin Sodium	Pravastatin Sodium	50	16
Buspirone Hcl	Buspirone Hcl	49	14
Warfarin Sodium	Warfarin Sodium	44	suppressed
Ezetimibe	Ezetimibe	43	suppressed
Jardiance	Empagliflozin	43	14
Azelastine Hcl	Azelastine Hcl	41	19
Clopidogrel	Clopidogrel Bisulfate	40	11
Doxycycline Hyclate	Doxycycline Hyclate	40	27
Ursodiol	Ursodiol	39	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	38	19
Bisoprolol Fumarate	Bisoprolol Fumarate	38	15
Duloxetine Hcl	Duloxetine Hcl	38	11
Estradiol	Estradiol	38	suppressed
Trospium Chloride	Trospium Chloride	38	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	14
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Sertraline Hcl	Sertraline Hcl	35	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	16
Baclofen	Baclofen	33	12
Tizanidine Hcl	Tizanidine Hcl	33	11
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Montelukast Sodium	Montelukast Sodium	30	11
Triamcinolone Acetonide	Triamcinolone Acetonide	29	21
Alendronate Sodium	Alendronate Sodium	28	suppressed
Azithromycin	Azithromycin	27	24
Ibuprofen	Ibuprofen	27	11
Januvia	Sitagliptin Phosphate	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Cefdinir	Cefdinir	26	23
Naproxen	Naproxen	26	suppressed
Diazepam	Diazepam	25	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Ketoconazole	Ketoconazole	25	16
Ondansetron Odt	Ondansetron	25	11
Donepezil Hcl	Donepezil Hcl	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	11
Benazepril Hcl	Benazepril Hcl	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Methadone Hcl	Methadone Hcl	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Ozempic	Semaglutide	20	suppressed
Sotalol	Sotalol Hcl	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Zaleplon	Zaleplon	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Minoxidil	Minoxidil	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Bumetanide	Bumetanide	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	14
Tradjenta	Linagliptin	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Yuvafem	Estradiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error